Cantini Pharmaceuticals submitted a listing to the Hong Kong Stock Exchange to lay out the field of organ fibrosis

Recently, according to the Hong Kong Stock Exchange, Beijing Cantini Pharmaceutical Co., Ltd. submitted a listing application to the main board of the Hong Kong Stock Exchange, and CICC is its sole sponsor.

獨角獸早知道Mar 17, 2022 08:24

Contini Pharmaceutical Co., Ltd. visits Hong Kong again IPO: annual income is 447 million, more than 90% comes from single product.

On February 28, Beijing Contini Pharmaceutical Co., Ltd. (hereinafter referred to as "Contini Pharmaceutical") submitted its listing application to the Hong Kong Stock Exchange again.

格隆滙新股Mar 4, 2022 21:00

Eleven companies submitted listing applications on the Hong Kong Stock Exchange on the same day. Of these, 3 were listed in the US and 1 SPAC was transferred to Hong Kong

The last time the Hong Kong Stock Exchange disclosed more than 10 new listing applications in a day was on June 30, 2021. On that day, the Hong Kong Stock Exchange disclosed 15 listing applications submitted in one day.

瑞恩資本RyanbenCapitalMar 1, 2022 13:41